Opin vísindi

Burden of rotavirus disease in young children in Iceland – Time to vaccinate?

Skoða venjulega færslu

dc.contributor Háskóli Íslands
dc.contributor University of Iceland
dc.contributor.author Kristinsdottir, Iris
dc.contributor.author Haraldsson, Asgeir
dc.contributor.author Löve, Arthur
dc.contributor.author Asgeirsdottir, Tinna Laufey
dc.contributor.author Thors, Valtyr
dc.date.accessioned 2022-02-04T12:00:57Z
dc.date.available 2022-02-04T12:00:57Z
dc.date.issued 2021-08-09
dc.identifier.citation Kristinsdottir, I., Haraldsson, A., Löve, A., Asgeirsdottir, T. L., & Thors, V. (2021). Burden of rotavirus disease in young children in Iceland – Time to vaccinate? Vaccine, 39(38), 5422–5427. https://doi.org/10.1016/j.vaccine.2021.07.053
dc.identifier.issn 0264-410X
dc.identifier.uri https://hdl.handle.net/20.500.11815/2882
dc.description © 2021 Published by Elsevier Ltd.
dc.description.abstract Background: Acute gastroenteritis poses a significant burden on young children, families, health care facilities and societies. Rotavirus is the most common pathogen, but rotavirus infections are vaccine preventable. Information on the epidemiology of gastroenteritis in Icelandic children has until now not been available and rotavirus vaccination is currently not offered to Icelandic infants. The objective of this study was to assess the burden of rotavirus acute gastroenteritis in young children in Iceland and determine the potential benefit of adding rotavirus vaccine to the Icelandic childhood immunization schedule. Methods: For a two-year period, children < 6 years old attending a children’s emergency department for acute gastroenteritis were recruited at the Children’s Hospital in Reykjavík, Iceland. Demographic information and Vesikari scores were registered. Stool samples were analyzed for pathogens. Duration of symptoms, treatment given, and secondary household infections were among the collected information. Annual cost of the infections in young children was estimated based on health care expenditures and lost days of parental work. Results: 325 children were included in the study, 75% of which were 24 months old. A pathogen was identified in 80% of cases, of which rotavirus was identified in 54%. Rotavirus caused a more severe disease than other pathogens, more often leading to fluid treatment in the emergency department and admissions. Median duration of rotavirus-illness was six days and caused a median of four days lost from work by parents. The estimated annual cost of rotavirus acute gastroenteritis was €2.9 million. Conclusions: Rotavirus causes significant disease burden in young children. Although rarely lifethreatening in high income countries, the costs for society are substantial. The inclusion of rotavirus vaccine in the national immunization schedule will reduce the disease burden and would be cost-saving in Iceland.
dc.description.sponsorship RANNÍS
dc.format.extent 5422-5427
dc.language.iso en
dc.publisher Elsevier
dc.relation.ispartofseries Vaccine;39(38)
dc.rights info:eu-repo/semantics/openAccess
dc.subject General Veterinary
dc.subject General Immunology and Microbiology
dc.subject Molecular Medicine
dc.subject Börn
dc.subject Bólusetningar
dc.subject Iðrakvef
dc.title Burden of rotavirus disease in young children in Iceland – Time to vaccinate?
dc.type info:eu-repo/semantics/article
dc.description.version Peer Reviewed
dc.identifier.journal Vaccine
dc.identifier.pmid 34384634
dc.identifier.doi 10.1016/j.vaccine.2021.07.053
dc.contributor.department Læknadeild (HÍ)
dc.contributor.department Faculty of Medicine (UI)
dc.contributor.school Heilbrigðisvísindasvið (HÍ)
dc.contributor.school School of Health Sciences (UI)


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu